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Summary.-Studies were made on the effects of 665 sera, from normal donors or
patients with various diseases, on B-lymphocyte colony formation in agar by mouse
spleen cells. Undiluted serum from most normal donors inhibited colony formation,
but43-53o% of sera from patients with histiocytic lymphoma, lymphocytic lymphoma
or Hodgkin's disease stimulated colony formation, serum activity correlating with
the stage of the disease. Moderate colony-stimulating activity was observed with
serum taken from patients with acute lymphoid or myeloid leukaemia following,
but not prior to, chemotherapy. Colony stimulating activity was not correlated with
the blood group of serum donors and could not be ascribed to the presence of endo-
toxin, red cells or mouse red cell haemagglutinins in the active sera. Elevated
colony stimulating activity wasnotobserved in serafrom patientswithnon-neoplastic
disorders of haemopoiesis or with diseases of other organ systems.
SEMI-SOLID cloning techniques for hae-
mopoietic cells have made it possible to
identify, and to some extent characterize,
specific factors stimulating or inhibiting
haemopoietic cell proliferation. Agar cul-
tures supporting neutrophilic and macro-
phage proliferation have been used to
identify and monitor the purification of
the specific glycoprotein, GM-colony-
stimulating factor (GM-CSF), required for
the proliferation of these cells in vitro
(Metcalf, 1970; Stanley and Metcalf, 1 969;
Sheridan and Metcalf, 1974; Stanley et al.,
1975). Similar studies have documented
the existence of different factors required
for eosinophil and megakaryocyte pro-
liferation in vitro (Metcalf et al., 1974,
1975). For erythropoietic colony forma-
tion in vitro, inclusion of erythropoietin
has been shown to be essential for colony
formation, which can be used as an in
vitro bioassay system for erythropoietin
(Stephenson et al., 1971; Iscove, Sieber
and Winterhalter, 1974).
Recently, a culture system has been
developed which supports the clonal
proliferation in semi-solid agar of mouse
B-lymphocytes (Metcalf et al., 1975a, b).
In this system, the addition of2-mercapto-
ethanol is essential for lymphocyte sur-
vival and proliferation. B-lymphocyte
colony formation appears to differ from
all other haemopoietic colony-forming
systems in not requiring the addition of a
specific growth-stimulating factor. How-
ever, this unique behaviour may be more
apparent than real. The cultures exhibit
a marked non-linearity between the num-
ber of cells cultured and the number of
colonies developing (Metcalf et al., 1975b).
Furthermore, some evidence has been
produced that 2-mercaptoethanol may
induce the formation in the culture dish
itself of material with stimulating or
potentiating activity on B-lymphocyte
colony proliferation (Metcalf, 1976).
Based on the ability of a granulocyte-
macrophage colony assay system to detect
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and measure GM-CSF levels in human
serum (Foster et al., 1968; Metcalf et al.,
1971), the present study was undertaken,
to determine the effects of adding serum
from normal subjects and patients with
various diseases on colony formation in
agar by B-lymphocytes from mouse spleen
tissue. A suboptimal culture system was
used deliberately, to facilitate detection
of sera with colony-stimulating activity.
MATERIALS AND METHODS
Serum collection.-Using aseptic pro-
cedures, blood was collected from normal
donors or patients with various diseases.
Clots were allowed to retract at room tem-
perature and the sera removed after centri-
fugation. Sera were stored at 400 in capped
bottles and in most cases were assayed
within 3 weeks of collection.
Culture 8ysteM.-All cultures were per-
formed in 35-mm plastic Petri dishes using
1-ml volumes of agar medium. All cultures
contained 25,000 spleen cells from 2-month-
old C57BL mice. Cell suspensions were
obtained by teasing the spleen apart with
needles in Eisen's balanced salt solution, and
disrupting the remaining clumps by gentle
pipetting, to produce a dispersed suspension
of single cells. Viable cell counts were
performed using eosin.
The culture medium was prepared by
mixing equal volumes of double strength
Dulbecco's modified Eagle's medium and
0.6% Bacto-Agar in distilled water (Difco,
Detroit, Michigan), the latter boiled for
2 min to dissolve and sterilize the agar, then
held at 37°C. The formula of the double
strength medium was: Dulbecco's modified
Eagle's medium HG Instant Culture Powder
H-16 (10 0 g) (Grand Island Biological Com-
pany, NewYork); double-glass-distilled water
420 ml; 3 ml L-asparagine (20 ,ug/ml); 1'5 ml
DEAE dextran (75 jg/ml) (Pharmacia,
Sweden, mol. wt.= 2 x 106/n/ = 0-70);
0-575 ml penicillin (200 u/ml); 0-375 ml strep-
tomycin (200 u/ml); 4 9 g NaH CO3; 190 ml
unheated foetal calf serum. After mixing
the medium and agar, sufficient 2-mercapto-
ethanol was added to produce a final molar
concentration of 5 x 10-5.
The required number of spleen cells was
added to the agar-medium mixture and 1-ml
volumes pipetted into each Petri dish.
Cultures were allowed to gel firmly at room
temperature for 10-20 min, then incubated
for 7 days at 37°C in a fully humidified
atmosphere of10% CO2in air.
B-lymphocyte colony formation is depen-
dent on the use ofan adequate batch offoetal
calf serum (FCS) and 6 of 9 batches tested
did not support colony formation. Most of
the present experiments were performed
using asingle batch, but for someexperiment$
a second batch offoetal calf serum was used,
and with this second batch it was necessary
to change from the 15% FCS used in the
above formula to 5% FCS to obtain com-
parable colony formation in control cultures.
Colony counts.-Colony counts were made
inthe conventional mannerusing an Olympus
dissection microscope at x 35 magnifications
and semi-indirect lighting. Discrete aggre-
gates of 50 or more cells were scored as
colonies.
Serum assays.-Batches of 20-30 human
sera were tested in each assay. For each
test, 0 1-ml volumes of the serum, diluted
1: 1, 1 : 4 and 1: 16 in normal saline, were
pipetted to duplicate culture dishes before
the addition of the cell suspension in agar
medium. The serum was carefully mixed
with the agar medium before gelling occurred.
In each set of assays, 3 types of controls
were used (a) negative controls: 4 dishes
containing 0 1 ml ofnormal saline, (b) positive
controls: 4 dishes containing 0 1 ml of 10%
washedsheep red cells, and (c) serum controls:
3 human sera used as controls in all experi-
ments. For each of these control sera,
duplicate dishes were prepared containing
0.1 ml of the serum diluted in two-fold
dilutions from 1: 1 to 1: 2048.
Because of the deliberate use of low
numbers of cultured cells to obtain sub-
optimal culture conditions (Metcalf et al.,
1975b) some fluctuation occurred between
different experiments in the level of B-
lymphocyte colony formation obtained in the
control cultures. Preliminary studies in 10
control experiments showed that cultures of
25,000 C57BL spleen cells usually produced
10 ± 5 colonies with the addition of 041 ml
of normal saline, 150-250 colonies with the
addition of 041 ml of 10% sheep red cells,
and 10-20 colonies with 041 ml of the 3
control human sera (usually at a dilution
between 1 : 4 and 1 : 16). Where control
values for a particular assay experiment
deviated from these predetermined control
values, a correction factor was applied to all
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colony counts from that particular experi-
ment. This correction factor varied from
0 5 to 2-0. In the 31 assay experiments
producing the data to be described, correction
factors were applied to the data from 11
experiments. The control data from the
remainingexperimentsfellwithintheexpected
range and the data from these experiments
were used uncorrected. On 4 other
occasions, assays failed twice due to incubator
failure and twice due to contamination of
media, and these assays were repeated.
Endotoxin assays-.Assays for endotoxin
in the human sera were based on the fact that
injection of as little as 041 ig endotoxin i.v.
to adult C57BL mice causes a rise in serum
GM-CSFlevels at3h, asassayed onmousebone
marrow cultures (Metcalf, 1971). Pairs of
3-month-old C57BL mice were injected i.v.
with 0-2 ml of the human serum to be tested,
and 3 h later the mice were killed and bled.
GM-CSF levels in these mouse sera were
assayed in cultures of 75,000 C57BL marrow
cells, using duplicate cultures containing
0.1 ml of 1: 6, 1: 18 and 1: 54 dilutions of
the sera (Metcalf, 1971).
Classification of patients-.The sera
analysed in the present study were kindly
supplied by the staffs of the Leukaemia-
Lymphoma Clinics ofthe following Melbourne
hospitals: Royal Melbourne Hospital, Peter
MacCallum Clinic, Alfred Hospital, Austin
Hospital and St Vincent's Hospital. Sera
were derived from portions of blood samples
being collected for routine clinical purposes.
No selection of patients was made. All
patients were adults and each was tested on
only a single occasion. Clinical data on
these patients were collected after the assays
had been completed and were compiled
without knowledge of the assay results. All
patients had been classified following bone
marrowand/orhistopathological examination.
In general, the criteria used for the classifi-
cation and staging of patients were those of
Hayhoe (1968) for the leukaemic patients and
those of Lukes (1968) for the lymphoma
patients.
RESULTS
General effects of human serum
Cultures of 25,000 C57BL spleen cells
exhibit some B-lymphocyte colony for-
mation in the presence of 2-mercapto-
ethanol, but the number of colonies
developing is below that expected if a
linear relationship existed between cell
numbers cultured and the number of
colonies developing (Metcalf et al., 1975b).
Thus, in 10 experiments in which control
cultures contained 0X1 ml normal saline,
the mean number of colonies developing
was 10 + 5. In cultures containing 0a1 ml
of 10% fresh sheep red cells, colony
formation is potentiated and becomes
linear with respect to the number of cells
cultured (Metcalf et al., 1975b). Thus, in
the above experiments, a mean of 207 ±
93 colonies was observed in cultures
containing 0-1 ml of 10% sheep red cells.
The addition of undiluted normal
human serum to cultures containing
25,000 spleen cells and 2-mercaptoethanol
either completely inhibited colony for-
mation or, as is shown in the 2 examples
in Fig. 1, reduced colony numbers below
those obtained in control cultures con-
taining saline. On progressive dilution,
normal human serum lost this inhibitory
activity and between dilutions of 1: 4 and
1: 16 many sera slightly increased colony
numbers above control levels. Dilution
of serum beyond this point failed to
influence colony numbers.
In contrast to this response to normal
serum, the addition of undiluted serum
from certain patients, e.g. with lympho-
cytic lymphomas as shown in Fig. ],
caused moderate to strong stimulation of
colony formation. On dilution, this stimu-
lating activity was progressively reduced,
and usually was no longer apparent at
dilutions ranging between 1: 16 and
1 : 128.
Colonies developing in the presence of
human serum had the gross morphology
of typical B-lymphocyte colonies. Mor-
phological examination of colony cells
showed that they were mononuclear cells,
many of which were identifiable as early
plasma cells. Analysis of membrane im-
munoglobulin showed that the majority
of colony cells reacted positively with a
fluorescein-conjugatedanti-it serum, which
is again typical of B-lymphocyte colony
cells (Metcalf et al., 1975b).
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FIG. 1.-Effect of 0-1 ml of serial dilutions ofhuman serum on the number of B-lymphocyte colonies produiced by 25,000 C57BI. spleen cells. 0 O Two sera from normal donors. * * Two
sera from patients with lymphocytic lymphoma. Hatched area is mean + s.d. ofcolony counts in
control cultures containing saline. All cultures contained 5 x 10-5M mercaptoethanol.
Spleenpopulations contain somegranu-
locytic and macrophage progenitor cells,
and many of the human sera tested
contained high levels of GM-CSF. How-
ever the frequency of GM-colony-forming
cells in C57BL spleens is low (3/105 cells)
and only occasional macrophage colonies
were observed in the present cultures
containing human serum. These macro-
phage colonies *ere readily distinguish-
able from B-lymphocyte colonies because
ofthe large size ofthe macrophage colony
cells.
Survey ofhuman sera
Based on these observations, a simpli-
fied protocol was adopted, in which sera
were tested at only 3 dilutions-I : 1,
1 : 4 and 1: 16. The results of this
survey are summarized in Tables I and II,
which present data only from cultures
containing 0.1 ml of undiluted sera, which
showed the maximum difference between
normal and abnormal sera.
Sera from only 12 of 119 normal blood
donors stimulated colony formation above
the basal levels occurring in cultures
containing saline (> 10 colonies per cul-
ture). In fact, most undiluted, normal
sera inhibited colony formation, and with
51 of the sera, colony formation was
completely suppressed, and only an occa-
sional viable cell was present in the culture
dishes.
Sera from patients with miscellaneous
non-neoplastic diseases of haemopoiesis,
such as haemolytic anaemia, iron defici-
ency or pernicious anaemia, and drug-
induced neutropenia, behaved in a similar
manner to sera from normal blood donors,
and only 2 of 47 sera stimulated colony
formation (Table I).
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TABLE 1.-B-lymphocyte ColonyStimulating Activity ofSerafrom Normial Donors and
Patients with Various Haemopoietic Diseases
Disease
Normal donors
Miscellaneous haemopoietic
disorders+
Histiocytic lymphoma
Hodgkin's disease
Lymphocytic lymphoma
Multiple myeloma
Chronic lymphoid leukaemia
Acute lymphoid leukaemia
Chronic myeloid leukaemia
Acute myeloid leukaemia
Myeloproliferative disorders
Number ofactive
serat/number tested
12/119
2/47
19/36
25/54
40/92
6/19
4/20
7/15
4/14
30/57
2/7
o/
/O
active sera
10
4
53
46
43
28
20
47
29
53
29
x2*
0*5
28-9
26-7
29-4
4-9
0-8
11 -8
2 -5
38-4
0-8
p
NS
<0-01
<0-01
<0-01
0*02<P<0-05
NS
<0-01
NS
<001
NS
* x2 and P values for differences in the number of active sera/number tested between each disease group
and the normal donors. NS=not significantly different
t Serum classified as active if > 10 colonies developed in cultures containing 0- I ml of undiluted serum.
I Includes patients with iron deficiency, macrocytic or haemolytic anaemia and polycythaemia vera.
TABLE 1I.-B-lymphocyte Colony Stimulating Activity ofSera
from Control Patients
Disease
Normal donors
Cancer ofnon-haemopoietic tissues
Chronic renal dis3ase
Cardiovascular disease
Autoimmune disease
Gastrointestinal disease
Miscellaneous other diseases*
Number ofactive serat/
number tested
12/119
1/19
6/71
0/20
1/31
1/9
3/35
* Excluding any disease of haemopoietic tissue.
t Sera were classified as active if > 10 colonies developed in cultures containing 0- 1 ml of undiluted
serum.
As shown in Table I, approximately
half of the sera tested from patients with
histiocytic lymphoma, Hodgkin's disease
or lymphocytic lymphoma stimulated B-
lymphocyte colony formation. Although
the number of patients surveyed was too
small to permit a realistic statistical
analysis, the data suggested strongly that
in each disease, serum activity was related
to the stage of the disease. Few sera
from Stage I and II patients stimulated
colony formation and sera from patients in
remission less frequently showed colony
formation than sera from Stage III and IV
patients (Table III). These differences
were also seen in the data on mean colony
TABLE III.-Correlation between Stimulating Activity ofSerum and Disease
Stage in Patients with Lymphoproliferative Diseases
Number of active sera */number tested (%)
A
Disease
Histiocytic lymphoma
Hodgkin's disease
Lymphocytic lymphoma
Total
Stage I Stage II
0/2 1/3
0/3 5/9
0/2 1/2
7/21 (33)
Stage III Stage IV
3/9 13/18
5/10 9/14
7/11 21/44
58/106 (55)
Remission
0/0
4/13
4/16
8/29 (28)
No data
available Total
2/4 19/36 (53)
2/5 25/54 (46)
7/17 40/92 (43)
* Serum classified as active if > 10 colonies developed in cultures containing 0.1 ml of undiluted serum.
active sera
10
5
8
0
3
11
9
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TABLE IV. Correlation between Level ofStimulating Activity of Serum and Disease
Stage in Patients with Lymphoproliferative Diseases
Mean number of colonies stimulated by 0- 1 ml of serum (range)
Disease
Histiocytic lymphoma
Hodgkin's disease
Lymphocytic lymphoma
Stage I
3
(0-5)
0
(0)
0
(0)
Stage II
19
(0-55)
25
(1-58)
27
(0-54)
numbers in cultures containing sera from
the various subgroups of patients (Table
IV). It can also be seen from Tables III
and IV that sera from Stage IV patients
with histiocytic lymphoma were the most
highly active of all sera analysed in the
survey.
In contrast to the sera from patients
with lympho-proliferative diseases, only
6 of 19 sera from patients with multiple
myeloma showed colony stimulating acti-
vity, and 2 of these were from patients
with associated severe renal disease. The
overall activity of these sera was also low,
as assessed from colony numbers in
cultures containing 041 ml of sera (mean
colony number - 13; range 0-84). A
similar low activity was observed with
sera from patients with chronic lymphoid
leukaemia (4/20 active; mean colony
number 7; range 0-48.)
Very few sera were available for testing
from adult patients with acute lymphoid
leukaemia and, of these, 7 of 15 showed
colony stimulating activity. On analysis
of the clirLical data an interesting corre-
lation emerged. Of 5 sera taken from
patients prior to chemotherapy, none was
active. Conversely, 7 of 8 sera known to
have been taken after initiation of chemo-
therapy were active in stimulating colony
formation. One serum sample was from
a patient in long term remission and was
inactive.
In view of the foregoing data, it was
unexpected to observe that 4 of 14 (29%)
sera from patients with chronic myeloid
leukaemia and 30 of 57 (530) sera from
patients with acute myeloid leukaemia
Stage III
17
(0-85)
21
(0-58)
12
(2-23)
Stage IV
56
(0-192)
41
(0-150)
26
(0-180)
No data
Remissioni available
25
(0-76)
8 6
(0_45) (0-14)
6 20
(0-26) (0-60)
All sera
37
(0 192)
22
(0-150)
19
(0-180)
stimulatedB-lymphocytecolonyformation.
All but 2 ofthe chronic myeloid leukaemia
patients were on chemotherapy, although
none had progressed to the stage of acute
transformation. The diagnosis of the
acute myeloid leukaemic patients was
based onroutine cytochemicalexamination
and parallel agar culture of the leukaemic
cells. Analysis ofthe disease status ofthe
AML patients showed that 13 of 22 (590o)
sera from relapse patients and 15 of 28
(54%o) sera from patients in full haemato-
logical remission exhibited stimulating
activity. In contrast, none of the sera
taken from 9 patients prior to treatment
exhibited stimulating activity. For
neither relapse nor remission sera was the
level of colony stimulating activity of the
sera as high as that of sera from the
lymphoma patients (relapse patients, mean
21 colonies (range 0-78); remission,
mean 15 colonies (range 0-52)). No
correlation was observed between the
serum stimulating activity for B-lympho-
cyte colony formation and the growth
pattern (Moore et al., 1974) of the leukae-
mic cells in standard agar cultures with
peripheral blood underlayers.
The activity was determined of sera
from patients with a number of different
diseases not involving haemopoietic tis-
sues. These data are shown in Table II,
in which it can be seen that sera from
none ofthese patient groups exhibited any
higher colony stimulating activity than
that observed with normal serum. Of
particular interest, in view ofthe apparent
effect of chemotherapy on serum activity
from acute leukaemic patients, was the
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fact that serum from cancer patients on
roughly comparable chemotherapy failed
to exhibit elevated stimulating activity.
It is also noteworthy that sera from
patients with a variety of autoimmune
diseases, some on cytotoxic drugs, also
failed to show elevated colony stimulating
activity.
Overall, the results with sera from 307
patients with leukaemia or lymphomas
(440o active) differed sharply from the
results with sera from 232 patients with
non-malignant disorders of haemopoiesis
or non-haemopoietic diseases (6%o active).
Because of the availability of culture
systems for assaying GM-CSF in human
sera, parallel assays of individual sera
were performed on C57BL marrow cells
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Fm. .2. Comparative assays on 24human sera
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C57BL, bone marrow cells ancl B-lympho-
cyte colonyformationby C57BL spleen cells.
Lines join (lata for same serum sample.
Horizontal lines incdicate upper limit of
activity shown by normal sera.
(75,000 cells/ml) for GM-CSF and on
C57BL spleen cells for their capacity to
stimulate B-lymphocyte colony formation.
In all, 100 sera were assayed in parallel,
and the results of a typical set of assays
are shown in Fig. 2. From the data for
the 24 sera shown in Fig. 2, it can be seen
that only one serum (from a patient with
lymphocytic lymphoma) showed both
elevated GM-CSF levels and B-lymphocyte
stimulating activity. For the remainder
there was no correspondence whatsoever
between the 2 assays, which were clearly
measuring different factors in the serum.
Possible causes ofobserved serumstimulating
activity
It has been reported that human AB
group serum is particularly effective in
supporting lymphocyte proliferation in
liquid culture systems. However, analy-
sis of 146 of the sera tested according to
donor blood groups failed to show any
overall difference between sera from
Groups A, 0, B or AB donors.
In previous work on B-lymphocyte
colony formation, addition of either endo-
toxin or intact red cells was shown to
potentiate colony formation (Metcalfet al.,
1975b; Metcalf, 1976). Since some of the
sera tested were known to have come
from patients with incidental infections,
some sera might have contained endo-
toxin. Several observations made this
possibility unlikely as the explanation of
the observed stimulating effects of serum.
The endotoxin effect is only observed with
particular batches of foetal calf serum
and, with the 2 batches used, addition of
20 ug endotoxin per culture failed to
potentiate colony formation. Assays for
endotoxin were made in C57BL mice on
15 sera with high colony stimulating
activity for B-lymphocytes. Although
the in vivo assay system is capable of
detecting 0-1 jug endotoxin (Metcalf, 1971)
no detectable endotoxin was observed in
any of the 15 sera.
Some of the sera tested contained
small numbers of intact red cells, and
many sera were haemolysed. On visual
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inspection of the 665 sera tested, no
correlation was observed between the
degree of haemolysis in the serum and
colony stimulating activity. This was
formally confirmed by measurement of
haemoglobin levels in 38 unselected sera.
Haemoglobin concentrations varied from
5 to 162 mg/100 ml but showed no corre-
lation with observed colony stimulating
activity (Fig. 3). Calculation showed that
01 ml of serum with a haemoglobin level
of 100 mg/100 ml contained the lysed
products of approximately 3 x 106 red
cells. As shown in Table V, the addition
of approximately the same number of
human red cells was capable ofstimulating
colony formation to the same degree as
observed with many active sera. How-
ever, two observations make red cells un-
likely to be the cause of the colony
stimulation observed with some sera.
Normal serum inhibited the stimulating
effects ofred cells, and when red cells were
suspended in normal serum, little colony
stimulation was observed. Finally, in the
vast majority of sera tested, no intact red
cells were present, only haemolysed pro-
ducts. It was found that osmotic haemo-
lysis, or a single cycle of freeze-thawing
(Table V) destroyed the capacity of red
cells to potentiate colony formation. In
contrast, the colony stimulating activity
ofserum was retained after freeze-thawing.
A final possibility investigated was
based on the report (Adler et al., 1970) that
the ability ofhuman sera to support PHA-
stimulated proliferation of mouse T-
lymphocytes is due to the presence ofanti-
mouse-red-cell haemagglutinins. Haem-
TABLE V. -Effects of Human Red Cells on B-lymiphocyte Colony Formation*
Added
Saline
l()0 X 106 sheep RBC
50 x 106 huiman- RBC
5 x 106 human RBC
2-5 x 106 hurnan RBC
125 x 106 human RBC
50 x 10W humain RBC
5 x 106 humain RBC
50 x 106 freeze-tha-wed
human RBC
50 x 106 freeze-thawed
human RBC
0-1 ml normal htuman
serum
Suspending me(lium AMlean number of
for adl(ditive colonies
Saline 8
Saline 490
Saline 325
Saline 65
Saline 92
Saline 8
Normal humain serumn 51
Normal human sertum 11
Saline
Normal humaii serum
12
0
0
* All cultures contained 25,000 (C57BL spleen cells, 5 x 10-5M
2-mnercaptoethanol and 0- 1 ml of saline or serum with or without
red cells. Mean colony counts of 4 replicate cultures.
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TABLE VI.-Comparison of Serum Haemagglutinin Titres with Colony Stimulating
Activity of 194 Human Sera*
Serum haemagglutinin
titres for mouse red
cells
0-1:2
1:4-1:8
1:16-1:32
1:64 or greater
No. active sera/
No. tested
(0)
2/19 (11)
26/90 (29)
20/69 (29)
4/16 (25)
Mean number of colonies
stimulated by the sera
(range)
6 -4
(0-50)
14-2
(0-192)
14-0
(0-126)
13-4
(0-138)
* Haemagglutinin titrations performed using 1% C57BL red cells in microtitre
plates, incubated at 37°C for 2 h, then held 15 h at 4°C.
agglutinin titrations were performed on
194 unselected sera whose colony stimu-
lating activity had been determined. As
shown in Table VI, no correlation was
observed between the haemagglutinin titre
and colony stimulating activity.
DISCUSSION
The present observations have shown
that sera from 43-53% of the patients
surveyed with histiocytic lymphoma,
lymphocytic lymphoma or Hodgkin's
disease, were capable of stimulating B-
lymphocyte colony formation by mouse
spleen cells. Until a comparable B-
lymphocyte culture system is available
for similar assays using human cells, this
intriguing observation must be interpreted
with some caution, as the target cells used
were from a foreign species.
Titration ofnormal serum showed that
most undiluted sera actually inhibited
colony formation but, on dilution, many
of these sera showed low levels of stimu-
lating activity. The observed stimulating
activity of undiluted sera from patients
with lymphoproliferative diseases suggests
that these sera may contain elevated levels
of a factor capable of stimulating B-
lymphocyte proliferation. In addition,
such sera either lack the inhibitory
material present in normal sera, or this
inhibitory activity is overridden by the
highstimulatingactivity. Furtherexperi-
ments on fractionated sera will be required
to determine which of these possibilities
is correct.
In individual sera, colony stimulating
activity for B-lymphocytes was not corre-
lated with capacity to stimulate granulo-
cytic and macrophage colony formation
by mouse bone marrow cells, and the
active factor therefore appears not to be
GM-CSF. Experiments have also made
it improbable that the B-lymphocyte-
stimulating activity of the sera is due to
endotoxin or red cells, two factors known
to be capable ofstimulating B-lymphocyte
colony formation (Metcalf et al., 1975b;
Metcalf, 1976).
It was of interest that stimulating
activity was low or not demonstrable in
serum from patients with 3 types of B-
lymphocyte disorders-multiple myeloma,
chronic lymphoid leukaemia and auto-
immune diseases. These obervations are
unexpected if the observed stimulation is
due to a B-lymphocyte-specific factor, and
the situation needs further investigation.
While most sera from pretreatment
patients with acute lymphoid or myeloid
leukaemia failed to stimulate colony
formation, a high proportion of sera from
patients on chemotherapy showed mode-
rate colony stimulating activity. This
strongly suggested that the active serum
factor might have originated from drug-
induced breakdown of normal or leukae-
mic cells. While this remains a possible
explanation, colony stimulating activity
was not observed in sera from cancer
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patients under treatment with a variety
of cytotoxic drugs.
The correlation observed in patients
with lymphoproliferative disorders, be-
tween disease stage and serum activity, is
also consistent with an origin ofthe active
factor from the breakdown of either the
tumour population or reacting host cells.
In view of the effect of chemotherapy on
serum activity in acute leukaemia, the
role of chemotherapy in the high serum
activity seen in Stage III and IV patients
needs further investigation. Preliminary
data from individual patients studied
sequentially suggest that the observed
serum activity is unlikely to be due to the
presence of cytotoxic drugs per se in the
serum. However, an active factor pro-
duced or released as a consequence ofdrug
action remains a possibility. Since
elevated serum activity was not observed
early in these diseases, it seems unlikely
that the factor being detected plays a
significant role in the development of
these diseases.
The observationthat sera from patients
with lymphoproliferative disorders can
stimulate lymphocyte proliferation in
vitro, raises the possibility that what is
being detected is analogous with the
lymphocyte-stimulating factors released
in vitro by mitogen-activated lympho-
cytes (Kasakura and Lowenstein, 1965;
Dutton et al., 1971). However, the signi-
ficance of the present observations cannot
be determined until further analytical
studies are performed on the nature and
origin of the active serum component.
The present agar cloning system appears
to be a useful technique for use in further
studies on this phenomenon.
The authors are indebted to Miss G.
Cousins and Miss E. Cain for technical
assistance throughout these experiments,
and to the haematology departments and
leukaemia-lymphoma clinics ofthe follow-
ing hospitals: Royal Melbourne Hospital;
Peter MacCallum Clinic; Alfred Hospital;
St Vincent's Hospital and the Austin
Hospital.
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